MiniMed MMED Cash Flow Statement (2025-2026)

NASDAQ MMED
$22.76 -0.56 (-2.40%)
As of: Sep 9, 2026 · 3:59 PM EDT
Reported Financials

MiniMed Quarterly Cash Flow Statement

Periods 6 quarters
Latest Jul 2026

MiniMed reported cash from operations of -$49.00M and free cash flow of -$90.00M for the quarter ended Jul 2026, down 159.0% year over year. This cash flow statement covers 6 quarters of results from Jan 2025 through Jul 2026, standardized by Business Quant from the company’s SEC filings.

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Jan2025 Apr2025 Jul2025 Jan2026 Apr2026 Jul2026
Operating Activities
Net Income -7.00M-169.00M-111.00M-185.00M
Share-based CompensationStock Comp. 9.00M8.00M10.00M
Deferred Taxes -2.00M-55.00M2.00M
Asset Writedowns and ImpairmentWritedown 8.00M3.00M6.00M
Cash from OperationsCash from Ops. 83.00M-170.00M-49.00M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort. 38.00M39.00M41.00M
Change in Working Capital
Change in ReceivablesChange Receivables 30.00M361.00M161.00M
Change in InventoryChange Inventory -22.00M-64.00M15.00M
Change in Accured ExpensesChange Accured Exp. 187.00M163.00M53.00M
Other Working Capital ChangesOther WC Changes -15.00M-31.00M25.00M
Investing Activities
Capital ExpendituresCapex 57.00M56.00M41.00M
Cash from Investing ActivitiesCash from Investing -57.00M-56.00M-41.00M
Financing Activities
Other financing activitiesOther financing -25.00M334.00M
Cash from Financing ActivitiesCash from Financing -25.00M512.00M
Additional items
Exchange Rate EffectFX Effect -1.00M
Change in Cash -91.00M
Free Cash FlowFCF -90.00M
Net Cash FlowNCF -90.00M